Cargando…

Therapy of murine squamous cell carcinomas with 2-difluoromethylornithine

Targeted overexpression of an ornithine decarboxylase (ODC) transgene to mouse skin (the K6/ODC mouse) significantly enhances susceptibility to carcinogenesis. While in most strain backgrounds the predominant tumor type resulting from initiation-promotion protocols is benign squamous papilloma, K6/O...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yan, Hu, Juncai, Boorman, David, Klein-Szanto, Andres, O'Brien, Thomas G
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2004
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC436064/ https://www.ncbi.nlm.nih.gov/pubmed/15175104 http://dx.doi.org/10.1186/1477-3163-3-10

Ejemplares similares

Difluoromethylornithine (DFMO) and Neuroblastoma: A Review
por: Tangella, Adarsh Vardhan, et al.
Publicado: (2023)

Clinical importance of eflornithine (α-difluoromethylornithine) for the treatment of malignant gliomas
por: Levin, Victor A, et al.
Publicado: (2018)

Difluoromethylornithine (DFMO) and AMXT 1501 inhibit capsule biosynthesis in pneumococci
por: Ayoola, Moses B., et al.
Publicado: (2022)

Difluoromethylornithine rebalances aberrant polyamine ratios in Snyder–Robinson syndrome
por: Stewart, Tracy Murray, et al.
Publicado: (2023)

α-Difluoromethylornithine-Induced Cytostasis is Reversed by Exogenous Polyamines, Not by Thymidine Supplementation
por: Hyvönen, Mervi T., et al.
Publicado: (2021)

Difluoromethylornithine (DFMO) Enhances the Cytotoxicity of PARP Inhibition in Ovarian Cancer Cells
por: El Naggar, Olivia, et al.
Publicado: (2022)

A pilot study of genomic‐guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high‐risk neuroblastoma
por: Kraveka, Jacqueline M., et al.
Publicado: (2022)

Metastasis of hormone-independent breast cancer to lung and bone is decreased by α-difluoromethylornithine treatment
por: Richert, Monica M, et al.
Publicado: (2005)

Combined Use of α‐Difluoromethylornithine and an Inhibitor of S‐Adenosylmethionine Decarboxylase in Mice Bearing P388 Leukemia or Lewis Lung Carcinoma
por: Nakaike, Shiro, et al.
Publicado: (1988)

Difluoromethylornithine, a Decarboxylase 1 Inhibitor, Suppresses Hepatitis B Virus Replication by Reducing HBc Protein Levels
por: Mao, Binli, et al.
Publicado: (2020)

Difluoromethylornithine attenuates isoproterenol-induced cardiac hypertrophy by regulating apoptosis, autophagy and the mitochondria-associated membranes pathway
por: Zhao, Yu, et al.
Publicado: (2021)

Difluoromethylornithine Is a Novel Inhibitor of Helicobacter pylori Growth, CagA Translocation, and Interleukin-8 Induction
por: Barry, Daniel P., et al.
Publicado: (2011)

The Polyamine Inhibitor Alpha-Difluoromethylornithine Modulates Hippocampus-Dependent Function after Single and Combined Injuries
por: Rosi, Susanna, et al.
Publicado: (2012)

Effect of an Inhibitor of Tumor Promotion, α‐Difluoromethylornithine, on Tumor Induction by Repeated Beta Irradiation in Mice
por: Ootsuyama, Akira, et al.
Publicado: (1993)

The First Insight Into the Supramolecular System of D,L-α-Difluoromethylornithine: A New Antiviral Perspective
por: Bojarska, Joanna, et al.
Publicado: (2021)

Potentiating NK cell activity by combination of Rosuvastatin and Difluoromethylornithine for effective chemopreventive efficacy against Colon Cancer
por: Janakiram, Naveena B., et al.
Publicado: (2016)

Alpha-Difluoromethylornithine, an Irreversible Inhibitor of Polyamine Biosynthesis, as a Therapeutic Strategy against Hyperproliferative and Infectious Diseases
por: LoGiudice, Nicole, et al.
Publicado: (2018)

The putative Tumor Suppressor VILIP-1 Counteracts Epidermal Growth Factor-Induced Epidermal-Mesenchymal Transition in Squamous Carcinoma Cells
por: Schönrath, Katharina, et al.
Publicado: (2012)

Correction: The putative Tumor Suppressor VILIP-1 Counteracts Epidermal Growth Factor-Induced Epidermal-Mesenchymal Transition in Squamous Carcinoma Cells
por: Schönrath, Katharina, et al.
Publicado: (2013)

Oligoamine analogues in combination with 2-difluoromethylornithine synergistically induce re-expression of aberrantly silenced tumour-suppressor genes
por: Wu, Yu, et al.
Publicado: (2012)

Role of obesity in a randomized placebo-controlled trial of difluoromethylornithine (DFMO) + sulindac for the prevention of sporadic colorectal adenomas
por: Zell, Jason A., et al.
Publicado: (2012)

Inhibiting Cycloxygenase and Ornithine Decarboxylase by Diclofenac and Alpha-Difluoromethylornithine Blocks Cutaneous SCCs by Targeting Akt-ERK Axis
por: Arumugam, Aadithya, et al.
Publicado: (2013)

Difluoromethylornithine Induces Apoptosis through Regulation of AP-1 Signaling via JNK Phosphorylation in Epithelial Ovarian Cancer
por: Hwang, Woo Yeon, et al.
Publicado: (2021)

Role of dietary polyamines in a phase III clinical trial of difluoromethylornithine (DFMO) and sulindac for prevention of sporadic colorectal adenomas
por: Raj, K P, et al.
Publicado: (2013)

Thymoquinone and Difluoromethylornithine (DFMO) Synergistically Induce Apoptosis of Human Acute T Lymphoblastic Leukemia Jurkat Cells Through the Modulation of Epigenetic Pathways
por: Alhosin, Mahmoud, et al.
Publicado: (2020)

Allogeneic transplantation of normal epidermal cells and squamous cell carcinomas in SENCAR mice.
por: Conti, C J, et al.
Publicado: (1986)

High Hydrostatic Pressure Therapy Annihilates Squamous Cell Carcinoma in a Murine Model
por: Mitsui, Toshihito, et al.
Publicado: (2020)

Heterogeneity of Gene Expression in Murine Squamous Cell Carcinoma Development—The Same Tumor by Different Means
por: Cohen, Noam, et al.
Publicado: (2013)

Cutaneous Squamous Cell Carcinoma in Patients with Hidradenitis Suppurativa
por: Racanelli, Elysia, et al.
Publicado: (2021)

Difluoromethylornithine (DFMO), an Inhibitor of Polyamine Biosynthesis, and Antioxidant N-Acetylcysteine Potentiate Immune Response in Mice to the Recombinant Hepatitis C Virus NS5B Protein
por: Lesnova, Ekaterina I., et al.
Publicado: (2021)

Inflammatory events during murine squamous cell carcinoma development
por: Gasparoto, Thais Helena, et al.
Publicado: (2012)

Oxic and Hypoxic Cells in a Murine Squamous Cell Carcinoma
por: Takai, Yoshihiro, et al.
Publicado: (1988)

Three-Dimensional Organoids Reveal Therapy Resistance of Esophageal and Oropharyngeal Squamous Cell Carcinoma Cells
por: Kijima, Takashi, et al.
Publicado: (2018)

Alcohol Metabolism Enriches Squamous Cell Carcinoma Cancer Stem Cells That Survive Oxidative Stress via Autophagy
por: Shimonosono, Masataka, et al.
Publicado: (2021)

Phase I study of intra-arterial interleukin-2 in squamous cell carcinoma of the head and neck.
por: Gore, M. E., et al.
Publicado: (1992)

Disulfiram (Antabuse) Activates ROS-Dependent ER Stress and Apoptosis in Oral Cavity Squamous Cell Carcinoma
por: Shah O’Brien, Priyanka, et al.
Publicado: (2019)

Cdx1 and c-Myc Foster the Initiation of Transdifferentiation of the Normal Esophageal Squamous Epithelium toward Barrett's Esophagus
por: Stairs, Douglas B., et al.
Publicado: (2008)

Temporal increase in the incidence of anal squamous cell carcinoma in Kentucky and factors associated with adverse outcomes
por: O'brien, Stephen J., et al.
Publicado: (2023)

ESM1 mediates NGFR-induced invasion and metastasis in murine oral squamous cell carcinoma
por: Chen, Chen, et al.
Publicado: (2016)

Evidence for the horizontal acquisition of murine AKR virogenes by recent horizontal infection of the germ line
por: O’Brien, SJ, et al.
Publicado: (1982)

Cannot write session to /tmp/vufind_sessions/sess_p0nm49thqieu7mblpfj3qkudjt